Page last updated: 2024-09-04

glg-v 13 and Myocardial Infarction

glg-v 13 has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berlin, KD; Chen, CL; Fazekas, T; Garrison, GL; Lazzara, R; Patterson, E; Sangiah, S; Scherlag, BJ; Schubot, FD; van der Helm, D	1

Other Studies

1 other study(ies) available for glg-v 13 and Myocardial Infarction

Article	Year
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperch Journal of medicinal chemistry, 1996, Jun-21, Volume: 39, Issue:13 Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Crystallography, X-Ray; Dogs; Electrophysiology; Heart Rate; Imidazoles; Lidocaine; Models, Molecular; Molecular Conformation; Molecular Structure; Myocardial Infarction; Tachycardia, Ventricular	1996

Article

Year

Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperch

Journal of medicinal chemistry, 1996, Jun-21, Volume: 39, Issue:13

Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Crystallography, X-Ray; Dogs; Electrophysiology; Heart Rate; Imidazoles; Lidocaine; Models, Molecular; Molecular Conformation; Molecular Structure; Myocardial Infarction; Tachycardia, Ventricular

1996